Work

Contrast-enhanced US Evaluation of Residual Hepatocellular Carcinoma Following Lenvatinib Combined with Anti-PD-1 Antibody Downstaging Therapy

Year: 2025
Type: article
Source: Radiology
Language: English
Subfield: Hepatology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4417384049
FWCI: 0.993
Cites: 34
Cited by: 2
Related to: